Clinical Trial Update: Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of AZD1480 in patients with solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD1480

Snippet

Sponsor: AstraZeneca | Conditions: Solid Malignancies | Phase 1 | Status: TERMINATED